Steele, H; Cheng, J; Willicut, A; Dell, G; Breckenridge, J; Culberson, E; Ghastine, A; Tardif, V; Herro, R. TNF superfamily control of tissue remodeling and fibrosis. Frontiers in Immunology. 2023; 14:1219907.

Dell, GJ; Steele, H; Cheng, JL; Breckenridge, JE; Willicut, A; Ghastine, A; Culberson, E; Herro, R. 1 Liver + 4 Diseases = n Drugs. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:176.11.

Breckenridge, JE; Dell, G; Steele, H; Cheng, JL; Ghastine, A; Culberson, E; Herro, R. Targeting Fibrosis to Improve Cancer Outcomes. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:245.04.

Cheng, JL; Steele, H; Breckenridge, J; Dell, G; Ghastine, A; Willicut, A; Herro, R. TL1A control of eczema and psoriasis. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:151.01.

Steele, H; Cheng, JL; Willicut, A; Dell, G; Breckenridge, J; Ghastine, A; Herro, R. Shedding LIGHT and TL1A on Pulmonary Fibrosis. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:176.07.

Song, B; Zhang, X; Steele, H; Chou, C; Ferchen, K; Salomonis, N; Herro, R; Grimes, HL. Live bacterial ligands universally regulate mTOR activity but are not essential for homeostatic innate immunity. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:65.05.

Miki, H; Kiosses, WB; Manresa, MC; Gupta, RK; Sethi, GS; Herro, R; Da Silva Antunes, R; Dutta, P; Miller, M; Fung, K; Ay, F; Broide, DH; Tumanov, AV; Croft, M. Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunction. Journal of Allergy and Clinical Immunology. 2023; 151:976-990.e5.

Manresa, MC; Miki, H; Miller, J; Okamoto, K; Dobaczewska, K; Herro, R; Gupta, RK; Kurten, R; Aceves, SS; Croft, M. A Deficiency in the Cytokine TNFSF14/LIGHT Limits Inflammation and Remodeling in Murine Eosinophilic Esophagitis. Journal of immunology (Baltimore, Md. : 1950). 2022.

Song, B; Ferchen, K; Chou, C; Zhang, X; Steele, H; Herro, R; Salomonis, N; Grimes, HL. 3194 – LIVE BACTERIAL LIGANDS PROGRAM CORE HEMATOPOIETIC GENE EXPRESSION. Experimental Hematology. 2022; 111:s142.

Steele, H; Song, B; Willicut, A; Grimes, HL; Herro, R. Isolation of primary immune cells from fibrotic skin, esophageal, and gut tissue. Journal of Immunological Methods. 2021; 497:113107.

Steele, H; Sachen, K; McKnight, AJ; Soloff, R; Herro, R. Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders. Frontiers in Immunology. 2021; 12:692127.

Manresa, MC; Chiang, AW T; Kurten, RC; Dohil, R; Brickner, H; Dohil, L; Herro, R; Akuthota, P; Lewis, NE; Croft, M; Aceves, SS. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype. Gastroenterology. 2020; 159:1778-1792.e13.

Herro, R; Miki, H; Sethi, GS; Mills, D; Mehta, AK; Nguyen, X; Feghali-Bostwick, C; Miller, M; Broide, DH; Soloff, R; Croft, M. TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling. Journal of immunology (Baltimore, Md. : 1950). 2020; 205:2414-2422.

Miki, H; Kiosses, WB; Herro, R; Croft, M. TNFSF14 (LIGHT) Induces Airway Smooth Muscle Contraction. Journal of immunology (Baltimore, Md. : 1950). 2020; 204:65.6.

Herro, R; Croft, M. Shedding LIGHT and TL1A on fibrosis. Journal of immunology (Baltimore, Md. : 1950). 2020; 204:234.5.